Hosted by Mary Ann Liebert, organized by BioConferences and Program Chair Dr. David B. Weiner, PhD. – University of Pennsylvania, USA

March 2 - 4, 2010
Sheraton New Orleans Hotel
New Orleans, LA


Agenda to date:


MARCH 2, 2010

Registration Opens: 9am - 5pm

Morning Sessions

Welcome Address from the Program Chairman: Enhancing DNA Vaccine Immunity in Vivo
David B. Weiner, PhDUniversity of Pennsylvania

Lunch Break

The Future of Vaccines from an Industry Perspective
John Shiver, PhDMerck

Human Immune Responses to Vaccination
Mark Slifka, PhDOSHU

Preclinical and Clinical Studies of DNA Vaccines for Biodefense
Connie Schmaljohn, PhDUSAMRIID

George KembleMedimmune

Break

Approaches to Influenza
Jukka Hartikka, PhDVical

SynCon™ DNA Vaccines for Infectious Diseases
NiranJan Sardesai, PhDInovio Biomedical Corporation

The Strengths and Weaknesses of Inducing Mismatched Immunity to Expand Cross-Protection Against Influenza Viruses
Gary Kobinger, PhDPHAC

5:30 - 7:30pm: Cocktail Social Hour in Exhibits Poster Area

MARCH 3, 2010

RV 144 ALVAC-HIV/AIDSVAX Study: Implications for HIV Vaccine Development
Col. Nelson Michael, MD, PhDWalter Reed Army Institute of Research, US Military HIV Research Program (MHRP)

Technologies for Improved Vaccines
Jeffrey Ulmer, PhDNovartis Vaccines & Diagnostics

Ron VeazeyTulane

Break

What is a Protective T Cell Response
Michael Betts, PhDUniversity of Pennsylvania School of Medicine

Heterologous Prime-Boost HIV Vaccines
Shan Lu, ME, PhDUniversity of Massachusetts Medical School

Clinical Experiences of HIV Genetic Vaccines
Britta Wahren, MD, PhDKarolinska Institute

Studies in Preclinical Macaque Models of DNA/MVA Vaccines
Harriet L. Robinson, PhDGeovax Inc.

Lunch Break

Optimization of DNA and Combination Vaccines in Macaques
George Pavlakis, MD, PhDNCI

Prime-boost Vaccination Regimens to Elicit Optimal Immune Responses
Mike Egan, PhDProfectus BioScience, Inc.

In Vivo Electroporation Enhances the Immunogenicity of ADVAX, a DNA-based HIV-1 Vaccine Candidate, in Healthy Volunteers
Sandhya Vasan, MDAaron Diamond AIDS Research Center

Genomic Signatures of DNA Vaccines
Jean Boyer, PhDUniversity of Pennsylvania

Immunogenicity of VRC DNA Vaccines for HIV, WNV and Influenza
Julie LedgerwoodVRC

Break

Selected Abstract Talks

Panel Discussion:
Stanley Plotkin, Joseph Kim, John Shiver, Andrew Murdin, Robert Menardi, Joe Lovett

Dinner Speaker:

Special Invited Speaker: Correlates of Protection from Infection
Stanley Plotkin, MDVaxconsult LLC

Presentation of Maurice Hilleman Award - John Shiver

Presentation of Richard Ginsberg Award - David Weiner

5:30 - 7:00pm: Cocktail Social Hour in Exhibits Poster Area

7:00pm: Gala Dinner in Banquet Hall

MARCH 4, 2010

Regulatory Gene Networks
Bin Wang, PhDChina Agricultural University

Therapeutic HPV DNA Vaccine Development
T.C. Wu, MD, PhDThe Johns Hopkins Medical Institutions

Approaches to HCV DNA Vaccines
Matti Sällberg, PhDTripep Pharma

Break

Antigen Specific Immunity after CTLA-4 Blockade: Investigation The Role of Prior Vaccination
Jianda Yuan, MD, PhDTripep Pharma

Robert MenardiMerial

DNA Vaccine Trials in Pigs to Evaluate Potential Medical and Veterinary Use
Eiji Kobayashi, MD, PhDJichi Medical School

Microbial Genes to Awaken Immunity Against Cancer Antigens
Freda Stevenson, PhDUniversity of Southampton, School of Medicine

Lunch Break

DNA Vaccine Based on Cancer-Testis Antigen, BORIS and IL21 Molecular Adjuvant in Extremely Effective For Treatment of Metastatic Disease
Michael AgadjanianThe Institute for Molecular Medicine

Comparative Performance Evaluation of Electroporation Mediated DNA Immunization Versus Conventional Vaccine Approaches
Brian LivingstonIchor Medical Systems

Immunization with Drug-Resistant HIV-1 Enzyme Genes
Maria IsaguliantsKarolinska Institute

Conserved Elements Vaccine for HIV-1 Gagp24 is Immunogenic in Mice and Macaques
James Mullins, PhDUniversity of Washington

Induction of Cross-clade Neutralizing Antibodies with a Prime/Boost Vaccine Strategy Focused on a Neutralizing Epitope
Susan Zolla-Pazner,PhDNYU Medical School

Selected Abstract Talks

Break

Transformative Technologies in the Vaccine Area - How Will We Know?
David Kaslow, MDMerck

Recent Advances in Malaria Vaccine Development
Ashley Birkett, PhDPATH MVI

Recombinant DNA Considerations in the EU - What Lies Ahead for Developers?
Ruxandra Draghia-Akli, MD, PhDEuropean Commission

DNA Vaccines: A View from Both Sides of the Fence and Both Sides of the Pond - Panel Discussion
David Kaslow, Ruxandra Draghlia-Akli, Ashley Birkett, Connie Schmaljohn, Alan Bernstein